Table 2.
Slopes of pressure-flow curve, critical closing pressure and slopes of EMGgg-PN from sickle cell disease subjects with and without OSAS using activated or hypotonic technique
SCD OSAS |
SCD Controls |
|||
---|---|---|---|---|
Activated | Hypotonic | Activated | Hypotonic | |
Slopes of EMGgg-PN (%/cm H2O) | ||||
Median | −3.3a | −3.8 | −11.6 | −1.9b |
Range | −7.1 to 3.5 | −4.0 to 3.3 | −27.9 to −1.9 | −11.3 to 1.5 |
95% CI | −9.6 to 4.5 | −7.8 to 3.6 | −17.8 to −8.0 | −5.9 to −1.6 |
Pcrit (cm H2O) | ||||
Median | −17.4 | −14.5 | −25.0 | −25.0c |
Range | −25.0 to −4.2 | −25.0 to −3.7 | −25.0 to −6.3 | −25.0 to −4.2 |
95% CI | −32.9 to 0.9 | −33.9 to −5.0 | −25.0 to −19.0 | −21.6 to −14.8 |
Slopes of pressure-flow curve (mL/sec*cm H2O) | ||||
Median | 10.6 | 25.7 | 4.5 | 10.8 |
Range | −5.1 to 60.3 | 1.0 to 72.7 | −10.3 to 37.4 | −21.2 to 32.4 |
95% CI | −27.1 to 65.3 | −24.5 to 87.1 | 1.4 to 14.8 | 3.7 to 18.0 |
Holding pressure (cm H2O) | ||||
Median | 3.1 | 3.3 | 1.2 | 1.5 |
Range | 1.3 to 7.0 | 1.3 to 7.8 | −1.8 to 5.1 | −1.0 to 5.0 |
95% CI | −0.8 to 8.0 | −1.0 to 8.8 | 0.4 to 2.4 | 0.9 to 2.5 |
Lowest pressure before arousal/apnea (cm H2O) | ||||
Median | −6.3d | −3.4e | −13.0 | −13.0 |
Range | −6.8 to −4.4 | −15.0 to −3.3 | −20.3 to −3.1 | −23.6 to −5.2 |
95% CI | −7.7 to −4.2 | −15.6 to 3.4 | −19.2 to −9.8 | −10.4 to −15.1 |
SCD controls had more negative slopes of EMGgg-PN than SCD OSAS when using the activated technique (P = 0.04).
For SCD controls, the slope of EMGgg-PN using the activated technique was more negative than that using the hypotonic technique (P < 0.001).
For SCD controls, Pcrit was more negative using the activated technique than the hypotonic technique (P = 0.03).
SCD controls had a more negative lowest pressure before arousal/apnea than SCD OSAS using the activated technique (P = 0.03).
SCD controls had a more negative lowest pressure before arousal/apnea than SCD OSAS using the hypotonic technique (P = 0.02).